Industry survey says costs of competing in Italy are too high
This article was originally published in Clinica
Executive Summary
Italian medical device and diagnostic companies spent approximately 4% of their combined turnover on competitive tendering processes in 1996. This cost is unnecessarily high and can be blamed on cumbersome bureaucracy built into the system to stamp out the type of corruption which was prevalent earlier this decade.